Pathology

Medicine & Life Sciences

1. Neoplasms 100%
2. Genes 47%
3. Neoplasm Metastasis 42%
4. Indoleamine-Pyrrole 2,3,-Dioxygenase 36%
5. Leukemia 36%
6. Lymphoma 34%
7. Stem Cells 32%
8. Breast Neoplasms 32%
9. Receptor, Fibroblast Growth Factor, Type 1 28%
10. Lung 27%
11. Proteins 26%
12. Survival 26%
13. Acute Myeloid Leukemia 25%
14. Kidney 25%
15. Gastric Inhibitory Polypeptide 24%
16. T-Lymphocytes 24%
17. MicroRNAs 23%
18. Phosphotransferases 23%
19. Urinary Bladder Neoplasms 22%
20. Pathology 22%
21. Therapeutics 22%
22. Glioblastoma 22%
23. Carcinoma 22%
24. Growth 21%
25. Carcinogenesis 20%
26. Biopsy 20%
27. Phenotype 19%
28. Glioma 19%
29. Mutation 19%
30. Neuroblastoma 19%
31. Bone and Bones 18%
32. Prostatic Neoplasms 18%
33. Light 18%
34. Cell Line 17%
35. Serum 17%
36. Adenocarcinoma 17%
37. Electrophoresis 17%
38. In Vitro Techniques 17%
39. Colorectal Neoplasms 16%
40. Cell Proliferation 16%
41. Staining and Labeling 16%
42. Activating Transcription Factor 3 16%
43. Cell Movement 16%
44. Colonic Neoplasms 16%
45. Lymph Nodes 15%
46. Gene Expression 15%
47. spasmolytic polypeptide 15%
48. Apoptosis 15%
49. Multiple Myeloma 15%
50. Inflammation 15%
51. Blood Proteins 14%
52. Pediatrics 14%
53. Chromosomes 14%
54. Renal Cell Carcinoma 14%
55. Loss of Heterozygosity 14%
56. Dendritic Cells 14%
57. Comparative Genomic Hybridization 14%
58. Pathologists 13%
59. Antibodies 13%
60. Myeloid-Derived Suppressor Cells 13%
61. Neoplastic Stem Cells 12%
62. Zebrafish 12%
63. Melanoma 12%
64. Brain 12%
65. Down-Regulation 12%
66. Up-Regulation 12%
67. Meningioma 12%
68. Genome 12%
69. Prostate 11%
70. Heart 11%
71. Biomarkers 11%
72. Surgical Pathology 11%
73. Cell Survival 11%
74. African Americans 11%
75. Squamous Cell Carcinoma 11%
76. Bone Marrow 11%
77. Transplants 11%
78. Chromosome Mapping 11%
79. Leucine 11%
80. Seizures 10%
81. Wiskott-Aldrich Syndrome Protein Family 10%
82. Radiation 10%
83. Mesenchymal Stem Cells 10%
84. Single Nucleotide Polymorphism 10%
85. Skin 10%
86. Necrosis 10%
87. Phospholipase D 10%
88. Mass Spectrometry 10%
89. Drug Therapy 10%
90. Tissue Inhibitor of Metalloproteinase-1 10%
91. Myeloproliferative Disorders 10%
92. Metaplasia 9%
93. Myeloid Cells 9%
94. DNA Methylation 9%
95. Enzymes 9%
96. DNA 9%
97. Transgenic Mice 9%
98. Messenger RNA 9%
99. Type 1 Diabetes Mellitus 9%
100. Medical Laboratory Science 9%